SCHEMBL2481050

SCHEMBL2481050

O=C1NC2C=CC=CC2C12CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6544503 0.66 NEK2 (0.30)
SCHEMBL14290351 0.60 NEK2 (0.36)
SCHEMBL7339315 0.60
SCHEMBL460791 0.55 ITGB3 (0.30)
SCHEMBL3313402 0.55
SCHEMBL13845917 0.54 BACE1 (0.47)
SCHEMBL3701448 0.53
SCHEMBL1032285 0.53 TDO2 (0.40)
SCHEMBL68772 0.53 DDB1 (0.30)
Water SCHEMBL10621554 0.52 GAA (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2373169-A1 IMIDAZOPYRAZINE SYK INHIBITORS Gilead Connecticut, Inc. (US) 2011-10-12 EP disclosed
WO-2010068257-A1 IMIDAZOPYRAZINE SYK INHIBITORS CGI PHARMACEUTICALS, INC. (US) 2010-06-17 WO disclosed